Molecular classification of prostate cancer using curated expression signatures
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular classification of prostate cancer using curated expression signatures
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 108, Issue 52, Pages 21276-21281
Publisher
Proceedings of the National Academy of Sciences
Online
2011-11-30
DOI
10.1073/pnas.1117029108
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular sampling of prostate cancer: a dilemma for predicting disease progression
- (2010) Andrea Sboner et al. BMC Medical Genomics
- Integrative Genomic Profiling of Human Prostate Cancer
- (2010) Barry S. Taylor et al. CANCER CELL
- TMPRSS2–ERG gene fusion is associated with low Gleason scores and not with high-grade morphological features
- (2010) Samson W Fine et al. MODERN PATHOLOGY
- Inactivation of p53 in breast cancers correlates with stem cell transcriptional signatures
- (2010) H. Mizuno et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PTENgenomic deletion is associated with p-Akt and AR signalling in poorer outcome, hormone refractory prostate cancer
- (2009) Kanishka Sircar et al. JOURNAL OF PATHOLOGY
- TMPRSS2–ERG gene fusion status in minute (minimal) prostatic adenocarcinoma
- (2009) Roula Albadine et al. MODERN PATHOLOGY
- Linking the p53 tumour suppressor pathway to somatic cell reprogramming
- (2009) Teruhisa Kawamura et al. NATURE
- A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity
- (2009) Rosa M. Marión et al. NATURE
- Direct cell reprogramming is a stochastic process amenable to acceleration
- (2009) Jacob Hanna et al. NATURE
- Suppression of induced pluripotent stem cell generation by the p53–p21 pathway
- (2009) Hyenjong Hong et al. NATURE
- The Ink4/Arf locus is a barrier for iPS cell reprogramming
- (2009) Han Li et al. NATURE
- Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate
- (2009) Brett S Carver et al. NATURE GENETICS
- Characterization of TMPRSS2-ERG Fusion High-Grade Prostatic Intraepithelial Neoplasia and Potential Clinical Implications
- (2008) J.-M. Mosquera et al. CLINICAL CANCER RESEARCH
- KLF6 and TP53 mutations are a rare event in prostate cancer: distinguishing between Taq polymerase artifacts and true mutations
- (2008) Laia Agell et al. MODERN PATHOLOGY
- Clinical significance of p53 alterations in surgically treated prostate cancers
- (2008) Thorsten Schlomm et al. MODERN PATHOLOGY
- Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis
- (2008) Bora Gurel et al. MODERN PATHOLOGY
- An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors
- (2008) Ittai Ben-Porath et al. NATURE GENETICS
- A causal role for ERG in neoplastic transformation of prostate epithelium
- (2008) O. Klezovitch et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Role of the TMPRSS2-ERG Gene Fusion in Prostate Cancer
- (2008) Scott A. Tomlins et al. NEOPLASIA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started